It has been reported that Novo Nordisk may have inadvertently allowed generics of its GLP-1 agonist semaglutide, the active ingredient in diabetes therapy Ozempic and ...

Learn to code’ is dead. So what the heck should you actually teach your kids in the age of AI? - IN FOCUS: Holly Baxter asks ...